Isabel Willius is an associate in the Frankfurt office and advises issuers and investment banks on initial public offerings and other capital market transactions.

Ms. Willius advises on:

  • IPOs
  • Spin-offs
  • Capital raisings
  • Equity-linked transactions
  • Debt offerings

Prior to joining Latham & Watkins, she worked in the Capital Markets Department at Latham in Frankfurt and Houston as a law clerk.

Ms. Willius' representative experience, working for the issuer or the underwriters, includes:

European IPOs

  • Douglas AG
  • Renk Group AG
  • Cheplapharm (proposed) 
  • Babbel (proposed)
  • MeinAuto Group (proposed)
  • Majorel Group Luxembourg S.A.
  • SUSE S.A.
  • Springer Nature AG & Co. KGaA (proposed)


  • Birkenstock Holding plc
  • CureVac

Spin-Offs (Frankfurt Stock Exchange)

  • Siemens AG/Siemens Energy AG
  • Allgeier SE/Nagarro SE

Capital Raisings (ABB / Rights Issues / PIPEs)

  • Nagarro SE
  • HomeToGo
  • TUI AG
  • Global Fashion Group S.A.
  • home24 SE

Debt Offerings

  • Mahle GmbH
  • TUI AG
  • Best Secret
  • Cheplapharm Arzneimittel GmbH  

Bar Qualification

  • Rechtsanwältin (Germany)


  • Second German State Exam, Higher Regional Court Mannheim
  • First German State Exam, University of Mannheim
  • LLB Bachelor of Law, University of Mannheim
  • Licence en Droit, University of Toulouse I (Capitole)

Languages Spoken

  • German
  • English
  • French